Global Myopia Treatment Devices market is growing at a CAGR of 7.57% during the forecast period from 2022 to 2027

The global myopia treatment devices market is growing at a CAGR of 7.57% during the forecast period from 2022 to 2027. The increase in demand for myopia treatment devices is predominantly due to the rising prevalence of myopia across the globe. Moreover, an increase in the adoption rate of myopia treatment devices is also expected to bolster the demand for these devices thereby leading to an increased market of myopia treatment devices in the upcoming years. Furthermore, an increase in product launches of various advanced myopia management devices and rising government initiatives to raise awareness among the population regarding myopia treatment are also anticipated to spur the demand for these devices during the forecasted period.

Myopia Treatment Devices: An Overview
Myopia, or nearsightedness, is a refractive vision disorder that causes blurred sight at a distance. It occurs when the length of the eye (known as axial length) is too great; myopia progresses as axial length increases with age. The devices such as eyeglasses, contact lenses, Ortho-K lenses, among others which are used to slow down the progression of myopia are termed as myopia treatment devices.

Download Sample Report- https://www.delveinsight.com/sample-request/myopia-treatment-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Recent Developmental Activities in the Myopia Treatment Devices Market:

• On May 25, 2021, CooperVision DreamLite® Ortho-K Lenses gained European approval for slowing the progression of myopia.
• On May 12, 2021, Euclid Systems Corporation, a global leader in advanced orthokeratology and proactive myopia management, launched the latest breakthrough in overnight orthokeratology lens, Euclid MAX in the US.
• On April 07, 2021, Menicon entered into a global collaboration with Johnson & Johnson Vision to bring forward therapeutic contact lens-related products and services to manage the progression of myopia in children.

Key Takeaways from the Myopia Treatment Devices Market Report Study

• Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Myopia Treatment Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Myopia Treatment Devices Market.
• Various opportunities available for the other competitor in the Myopia Treatment Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Myopia Treatment Devices market growth in the coming future?

COVID19 Impact on Myopia Treatment Devices Market
The unprecedented COVID-19 impact had sluggish the market growth for myopia treatment devices. This is due to the implementation of stringent lockdowns across the nation, reduction in clinic visits due to reluctance among patients during the pandemic, among others. However, a sudden shift towards digital or e-learning approaches from classroom-based learning has subsequently increased myopia and its progression among the students. For instance, as per the report published by UNESCO in the year 2020, approximately 1.37 billion students from more than 130 countries globally were affected by the pandemic as the schools and universities adopted digital learning during the pandemic to curb the infection. Thus, it is expected to increase the risk of myopia among the children which will increase the demand for the myopia treatment devices during the post-pandemic situation, thus the market will gain normalcy.

Check more details of market size- https://www.delveinsight.com/report-store/myopia-treatment-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Myopia Treatment Devices Market

Myopia Treatment Devices Market By Treatment (Corrective Lenses, Laser Eye Surgery, Lens Implant Surgery), By Product Type (Eyeglasses, Contact Lenses, Ortho-K Lenses, Phakic Intraocular Lenses, Excimer Laser Refractive Surgery Devices), By End-User (Hospitals, Specialty Clinics, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2027 owing to the growing burden of myopia across the globe and high adoption rate of myopia treatment devices.
Myopia Treatment Devices Market Dynamics
The market for myopia treatment devices is gaining pace at present owing to the growing myopia cases across the globe. According to the World Health Organization (WHO), myopia is a type of uncorrected refractive error that is the most common cause of vision impairment among patients. Also, myopia is associated with a higher risk of cataracts and glaucoma. Moreover, as per the projections mentioned by the WHO, myopia and high myopia would affect 52% (4949 million) and 10.0% (925 million), respectively, of the world's population by the year 2050.

Myopia Treatment Devices Market Segment Analysis
• Myopia Treatment Devices Market By Treatment (Corrective Lenses, Laser Eye Surgery, Lens Implant Surgery)
• Myopia Treatment Devices Market By Product Type (Eye Glasses, Contact Lenses, Ortho-K Lenses, Phakic Intraocular Lenses, Excimer Laser Refractive Surgery Devices)
• Myopia Treatment Devices Market By End-User (Hospitals, Specialty Clinics, and Others)
• Myopia Treatment Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Myopia Treatment Devices Market is expected to witness the fastest growth of Asia Pacific
Among all the regions, Asia Pacific is anticipated to register the fastest growth in the myopia treatment devices market during the forecasted period. This is owing to the rising prevalence of the targeted population. For instance, according to the report published by the Government of Singapore in the year 2019, the prevalence of myopia in Singapore is among the highest in the world, with 65% of children being myopic by 6, and 83% of young adults being myopic. Also, Singapore is often labelled as the "Myopia Capital of the World". It is projected that 80 to 90% of all Singaporean adults above 18 years old would be myopic and 15 to 25% of these individuals may have high myopia by the year 2050.

Myopia Treatment Devices Market Companies
Some of the key market players operating in the Myopia Treatment Devices market include CooperVision (CooperCompanies), Johnson & Johnson, Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes., SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., HORUS S.n.C. di Risoldi & C - P, Falco lenses AG, and others.

Request Sample Report- https://www.delveinsight.com/sample-request/myopia-treatment-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Myopia Treatment Devices Market Report Introduction
2. Myopia Treatment Devices Market Executive summary
3. Regulatory Analysis
4. Myopia Treatment Devices Market Key factors analysis
5. Myopia Treatment Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Myopia Treatment Devices Market
7. Myopia Treatment Devices Market layout
8. Myopia Treatment Devices Global Company Share Analysis - Key 3-5 Companies
9. Myopia Treatment Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Do you have any query or doubt? Visit here- https://www.delveinsight.com/report-store/myopia-treatment-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.